HRMY logo

HRMY Cash from financing

annual CFF:

-$11.00M+$94.56M(+89.58%)
December 31, 2024

Summary

  • As of today (June 29, 2025), HRMY annual cash flow from financing activities is -$11.00 million, with the most recent change of +$94.56 million (+89.58%) on December 31, 2024.
  • During the last 3 years, HRMY annual CFF has fallen by -$18.41 million (-248.21%).
  • HRMY annual CFF is now -105.26% below its all-time high of $209.16 million, reached on December 31, 2020.

Performance

HRMY Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

quarterly CFF:

-$352.00K+$2.39M(+87.16%)
March 31, 2025

Summary

  • As of today (June 29, 2025), HRMY quarterly cash flow from financing activities is -$352.00 thousand, with the most recent change of +$2.39 million (+87.16%) on March 31, 2025.
  • Over the past year, HRMY quarterly CFF has increased by +$3.28 million (+90.31%).
  • HRMY quarterly CFF is now -100.26% below its all-time high of $136.62 million, reached on September 30, 2020.

Performance

HRMY quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

TTM CFF:

-$7.71M+$3.28M(+29.85%)
March 31, 2025

Summary

  • As of today (June 29, 2025), HRMY TTM cash flow from financing activities is -$7.71 million, with the most recent change of +$3.28 million (+29.85%) on March 31, 2025.
  • Over the past year, HRMY TTM CFF has increased by +$104.88 million (+93.15%).
  • HRMY TTM CFF is now -103.29% below its all-time high of $234.53 million, reached on September 30, 2020.

Performance

HRMY TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHRMYcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HRMY Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+89.6%+90.3%+93.2%
3 y3 years-248.2%-125.5%-187.8%
5 y5 years-107.7%-100.5%-103.9%

HRMY Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-248.2%+89.6%-110.3%+99.4%-168.5%+93.3%
5 y5-year-105.3%+89.6%-100.3%+99.4%-103.3%+93.3%
alltimeall time-105.3%+89.6%-100.3%+99.4%-103.3%+93.3%

HRMY Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$352.00K(-87.2%)
-$7.71M(-29.8%)
Dec 2024
-$11.00M(-89.6%)
-$2.74M(+133.3%)
-$11.00M(-82.2%)
Sep 2024
-
-$1.18M(-65.9%)
-$61.78M(-46.6%)
Jun 2024
-
-$3.45M(-5.2%)
-$115.70M(+2.8%)
Mar 2024
-
-$3.63M(-93.2%)
-$112.59M(+6.7%)
Dec 2023
-$105.55M(-1642.9%)
-$53.52M(-2.9%)
-$105.55M(+113.8%)
Sep 2023
-
-$55.10M(>+9900.0%)
-$49.37M(-734.8%)
Jun 2023
-
-$339.00K(-109.9%)
$7.78M(-12.3%)
Mar 2023
-
$3.41M(+28.3%)
$8.87M(+29.6%)
Dec 2022
$6.84M(-7.8%)
$2.66M(+29.7%)
$6.84M(-39.2%)
Sep 2022
-
$2.05M(+173.3%)
$11.26M(+26.6%)
Jun 2022
-
$750.00K(-45.8%)
$8.89M(+1.2%)
Mar 2022
-
$1.38M(-80.4%)
$8.79M(+18.5%)
DateAnnualQuarterlyTTM
Dec 2021
$7.42M(-96.5%)
$7.07M(-2359.4%)
$7.42M(-1017.1%)
Sep 2021
-
-$313.00K(-148.3%)
-$809.00K(-100.6%)
Jun 2021
-
$648.00K(+5300.0%)
$136.13M(+0.5%)
Mar 2021
-
$12.00K(-101.0%)
$135.41M(-35.3%)
Dec 2020
$209.16M(+45.5%)
-$1.16M(-100.8%)
$209.16M(-10.8%)
Sep 2020
-
$136.62M(<-9900.0%)
$234.53M(+59.8%)
Jun 2020
-
-$67.00K(-100.1%)
$146.77M(-26.4%)
Mar 2020
-
$73.76M(+204.7%)
$199.31M(+38.6%)
Dec 2019
$143.77M(+565.1%)
$24.21M(-50.5%)
$143.77M(+20.2%)
Sep 2019
-
$48.87M(-6.9%)
$119.56M(+69.1%)
Jun 2019
-
$52.48M(+188.1%)
$70.69M(+288.1%)
Mar 2019
-
$18.22M
$18.22M
Dec 2018
$21.61M
-
-

FAQ

  • What is Harmony Biosciences Holdings annual cash flow from financing activities?
  • What is the all time high annual CFF for Harmony Biosciences Holdings?
  • What is Harmony Biosciences Holdings annual CFF year-on-year change?
  • What is Harmony Biosciences Holdings quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Harmony Biosciences Holdings?
  • What is Harmony Biosciences Holdings quarterly CFF year-on-year change?
  • What is Harmony Biosciences Holdings TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Harmony Biosciences Holdings?
  • What is Harmony Biosciences Holdings TTM CFF year-on-year change?

What is Harmony Biosciences Holdings annual cash flow from financing activities?

The current annual CFF of HRMY is -$11.00M

What is the all time high annual CFF for Harmony Biosciences Holdings?

Harmony Biosciences Holdings all-time high annual cash flow from financing activities is $209.16M

What is Harmony Biosciences Holdings annual CFF year-on-year change?

Over the past year, HRMY annual cash flow from financing activities has changed by +$94.56M (+89.58%)

What is Harmony Biosciences Holdings quarterly cash flow from financing activities?

The current quarterly CFF of HRMY is -$352.00K

What is the all time high quarterly CFF for Harmony Biosciences Holdings?

Harmony Biosciences Holdings all-time high quarterly cash flow from financing activities is $136.62M

What is Harmony Biosciences Holdings quarterly CFF year-on-year change?

Over the past year, HRMY quarterly cash flow from financing activities has changed by +$3.28M (+90.31%)

What is Harmony Biosciences Holdings TTM cash flow from financing activities?

The current TTM CFF of HRMY is -$7.71M

What is the all time high TTM CFF for Harmony Biosciences Holdings?

Harmony Biosciences Holdings all-time high TTM cash flow from financing activities is $234.53M

What is Harmony Biosciences Holdings TTM CFF year-on-year change?

Over the past year, HRMY TTM cash flow from financing activities has changed by +$104.88M (+93.15%)
On this page